Invitation to presentation of MEDS Q2 2026 Interim Report on July 21, 2026
Invitation to presentation of MEDS Q2 2026 Interim Report on July 21, 2026
MEDS will publish its interim report for the second quarter on July 21, 2026, at 07:30 CEST. A webcast presentation will be held for analysts, media, and investors at 09:30 CEST the same day.
The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.
The presentation will be conducted in English and broadcast live online. Please email ir@meds.se to receive a link to the live presentation (at latest 09:00 CEST on July 21).
A recorded version of the presentation will be available later at:
Rapporter och presentationer | MEDS Investor Relations
Schedule for the 21st of July:
- 07:30 CEST – Publication of the Q2 report
- 09:30 CEST – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola
For further information, please contact:
MEDS Investor Relations
E-mail: ir@meds.se
Web: https://corporate.meds.se/
About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.
Certified advisor is FNCA.